The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Globe Investor

News Sources

Take control of your investments with the latest investing news and analysis

Press release from Business Wire

Medidata Solutions to Present at the Raymond James 34th Annual Institutional Investors Conference

Friday, March 01, 2013

Medidata Solutions to Present at the Raymond James 34th Annual Institutional Investors Conference08:30 EST Friday, March 01, 2013 NEW YORK (Business Wire) -- Medidata Solutions (NASDAQ: MDSO), a leading global provider of cloud-based clinical development solutions, today announced that Bryan Spielman, executive vice president of strategy and corporate development, and Cory Douglas, chief financial officer, will present at the Raymond James34th Annual Institutional Investors Conference on March 6, 2013, at 8:40 a.m. EST in Orlando, FL. A live audio webcast will be available on the “Investor” section of Medidata's website at http://investor.mdsol.com. Please visit the website at least 15 minutes prior to the event to register, download and install any necessary audio or video software to access the presentation. For those unable to participate in the live webcast, a replay will be archived on the “Investor” section of Medidata's website at http://investor.mdsol.com for a limited time following the conference. About Medidata Solutions Worldwide Medidata Solutions is a leading global provider of cloud-based clinical development solutions that enhance the efficiency of customers' clinical trials. Medidata's advanced platform lowers the total cost of clinical development by optimizing clinical trials from concept to conclusion: from study and protocol design, trial planning and budgeting, site negotiation, clinical portal, trial management, randomization and trial supply management, clinical data capture and management, safety events capture, medical coding to business analytics. Our diverse life science customer base spans biopharmaceutical companies, medical device and diagnostic companies, academic and government institutions, CROs and other research organizations, and includes more than 20 of the top 25 global pharmaceutical companies as well as organizations of all sizes developing life-enhancing medical treatments and diagnostics. Investor Contact:Medidata SolutionsHulus Alpay212.419.1025halpay@mdsol.comorMedia Contact:EdelmanGeoff Curtis212.277.3718geoff.curtis@edelman.com